Fairlife Milk
Company’s animal welfare claims – and brand name – face increasing scrutiny.
Global Institute of Stem Cell Therapy and Research
In May 2020, a class-action lawsuit was filed against Global Institute of Stem Cell Therapy and Research for allegedly:
- Misleadingly representing that its stem cell therapy treatment can treat multiple diseases – including sickle cell anemia, leukemia, lymphoma, and thalassemia – when, according to the complaint, the treatment does not treat such diseases and is not approved by the FDA;
- Failing to disclose the risks associated with the treatment;
- Making false statements about one of the co-founder’s education, academic appointments, and clinical experience; and
- Falsely claiming that the defendants are affiliated with and have stem cell clinics set up at reputable medical institutions when, according to plaintiffs, they are not affiliated with and do not have clinics at the institutions.
Plaintiffs also claim that the defendants are not licensed to perform stem cell treatments in the United States. (Mendez et al v. Global Institute of Stem Cell Therapy and Research USA et al, Case No. 20-cv-915, S.D. Cal.)
The Latest
CATrends: Baseball Ticket Prices
Consumers balk at hidden junk fees.
Benjamin Moore: Timeless
As years pass and life shifts, the walls around us quietly hold every moment.
Consumer Cellular
TINA.org uncovers the limits of this carrier’s “unlimited” data plans.
There Should Be a Price to Pay for Knowingly Lying to Consumers
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.